EMVISION MEDICAL DEVICES LTD
ASX:EMVHealth Care Equipment & ServicesToday’s holders own 92.0% of what they think they own, once every option and right converts.
Runway 2–4 quarters; share count grew 9% in 24 months; 1 cash raise in 24 months
EMVISION MEDICAL DEVICES LTD's ordinary share count rose 8.7% between September 2024 and May 2026, its latest share-count filing, to 93M shares. The company completed one capital raise in that period, a Placement and SPP in September 2025 for A$14.0M. Options and rights on issue could convert into 8M new shares, representing 8.7% of the current share count, with none in the money; the nearest expiry is in June 2027. The company has 2 to 4 quarters of funding at the recent spend rate, based on its September 2026 quarterly. No proposed securities issues are currently pending.
Quick answers · 4
When did EMV last raise capital?
The last capital raise in Emvision Medical Devices's filings is Placement and SPP of $14.0M announced 17 Sept 2025, one of 1 cash raises in 24 months.
How much placement capacity does EMV have left?
About 95% of the 15% placement capacity left, about 5% used in 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.
When do EMV's options expire?
Unexercised options and rights equal 8.7% of Emvision Medical Devices's shares on issue; the nearest expiry is June 2027.
How much has EMV's share count grown?
Emvision Medical Devices has 93.0M shares on issue as at 28 Oct 2026, up 8.7% over 24 months according to its Appendix 2A filings.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 11 Sept 2026 | 3G · unquoted | EMV : ORDINARY FULLY PAID | 93.0M | Appendix 3G |
| 12 May 2026 | 2A · quoted issue | EMV : ORDINARY FULLY PAID | 93.0M | Appendix 2A |
| 10 Apr 2026 | 3G · unquoted | EMV : ORDINARY FULLY PAID | 92.9M | Appendix 3G |
| 6 Feb 2026 | 3G · unquoted | EMV : ORDINARY FULLY PAID | 92.9M | Appendix 3G |
| 2 Jan 2026 | 3H · cancellation | EMV : ORDINARY FULLY PAID | 92.9M | Appendix 3H |
Securities on issue over time
Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.
Capital raises
1 cash raise in the last 24 months · 0 in the last 12 months
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
- Price-triggered7.4M · 8.0% of sharesOptions and warrants — they convert when the share price clears their exercise price.At least 5.4M of it states no exercise price — that much cannot be called in or out of the money.
- Condition-triggered656k · 0.7% of sharesPerformance and incentive rights — they convert when a hurdle is met, not at a price, and can lapse to nothing.
Exercise price on record: 2.0M priced, 6.1M where the filing never states one. A security with no exercise price is never counted in the money — nothing is paid to convert it, so there is no price for it to be above.
Each figure is the filing’s own count of securities, not a share count — a 2A never states what one security converts into.
An exercise price is on record for only 24.8% of this supply, so what is in the money today is not a measurement — the tile above reads “—” for that reason. Of the priced supply, 0 is in the money at $1.50 today. At double today’s price it is 1.2M (1.3% of shares).
- Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
- 6.1M (75.2% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| EMVAO | Performance rights | Condition-triggered | — | 30 June 2027 | 27k | Filing Meeting |
| EMVO | Options | Price-triggered, no exercise price stated | — | 3 Nov 2027 | 5.4M | Filing |
| EMVAW | Options | Price-triggered | $3.15 | 31 Dec 2027 | 600k | Filing |
| EMVAU | Performance rights | Condition-triggered | — | 30 June 2028 | 2k | Filing Meeting |
| EMVAAA | Options | Price-triggered | $3.00 | 31 Dec 2028 | 200k | Filing |
| EMVAX | Options | Price-triggered | $2.60 | 11 Feb 2029 | 800k | Filing |
| EMVAV | Performance rights | Condition-triggered | — | 30 June 2029 | 13k | Filing Meeting |
| EMVAA | Options | Price-triggered | $2.68 | 6 Aug 2029 | 400k | Filing |
| EMVAZ | Performance rights | Condition-triggered | — | 30 June 2030 | 32k | Filing Meeting |
| EMVAY | Performance rights | Condition-triggered | — | 11 Aug 2030 | 150k | Filing Meeting |
| EMVAB | Performance rights | Condition-triggered | — | 6 Feb 2031 | 100k | Filing Meeting |
| EMVAC | Performance rights | Condition-triggered | — | 10 Apr 2031 | 60k | Filing Meeting |
| — | Performance rights | Condition-triggered | — | 30 June 2031 | 273k | Filing Meeting |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.
A condition-triggered class has no exercise price and usually no expiry: what it vests on is set by a shareholder resolution, not by the register. Where the company lodged a notice of meeting before the class first appears here, it is linked as “Meeting” — that is where terms of this kind are put to shareholders. It is not confirmation that the document sets this class’s conditions, and no link appears where there is no such filing.
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 22 Apr 2026 | Carmel Monaghan | Buy on-market | 10k | 200k | — | $18k | 3Y notice |
| 31 Dec 2025 | Mr John Keep | Sell | — | 300k | — | — | 3Y notice |
| 18 Nov 2025 | Carmel Monaghan | Other | — | 200k | — | — | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.